Bobby P. C. Koeleman spends much of his time researching Genetics, Immunology, Allele, Genome-wide association study and Epilepsy. The various areas that he examines in his Immunology study include Activated protein C resistance, PTPN22, Protein C deficiency, Protein C and Type 1 diabetes. His Protein C deficiency study incorporates themes from Factor V Leiden, Molecular biology, Protein S and Gene mutation.
He interconnects Disease, Genetic predisposition and Genotype in the investigation of issues within Allele. His Genome-wide association study research includes elements of SNP, Genetic association and Heritability. His Epilepsy research includes themes of Intellectual disability, Missense mutation and Pediatrics.
Bobby P. C. Koeleman mainly focuses on Genetics, Epilepsy, Immunology, Genome-wide association study and Allele. His research in Epilepsy intersects with topics in Phenotype, Missense mutation, Pediatrics and Bioinformatics. His Immunology research is multidisciplinary, relying on both Type 1 diabetes, Case-control study, Genetic predisposition and Genotype.
His research integrates issues of Odds ratio and Internal medicine in his study of Genotype. The study incorporates disciplines such as SNP, PTPN22, Genetic variation and Heritability in addition to Genome-wide association study. The Allele study combines topics in areas such as Disease, Rheumatoid arthritis and Polymerase chain reaction.
The scientist’s investigation covers issues in Epilepsy, Genetics, Pediatrics, Genome-wide association study and Phenotype. His Epilepsy study combines topics in areas such as Internal medicine, Cohort, Confounding and Missense mutation. Bobby P. C. Koeleman undertakes multidisciplinary studies into Genetics and Genomic medicine in his work.
The concepts of his Pediatrics study are interwoven with issues in Meta-analysis, Refractory juvenile myoclonic epilepsy and Juvenile myoclonic epilepsy. The subject of his Genome-wide association study research is within the realm of Single-nucleotide polymorphism. His Single-nucleotide polymorphism research incorporates themes from Pharmacogenetics and Risk factor.
Bobby P. C. Koeleman focuses on Epilepsy, Genetics, Pediatrics, Missense mutation and Phenotype. His Epilepsy research is multidisciplinary, incorporating perspectives in Quality of life, Affect and Medical record. His studies deal with areas such as Meta-analysis, Neurology, CBCL and Refractory juvenile myoclonic epilepsy as well as Pediatrics.
His research in Missense mutation intersects with topics in Encephalopathy, Intellectual disability, Cerebellar atrophy, Endocytosis and Physiology. Bobby P. C. Koeleman studied Generalized epilepsy and Comorbidity that intersect with Genome-wide association study. His study with Genome-wide association study involves better knowledge in Single-nucleotide polymorphism.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mutation in blood coagulation factor V associated with resistance to activated protein C
Rogier M. Bertina;Bobby P. C. Koeleman;Ted Koster;Frits R. Rosendaal.
Nature (1994)
Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families.
Bobby P.C. Koeleman;Pieter H. Reitsma;C.F. Allaart;Rogier M. Bertina.
Blood (1994)
15q13.3 microdeletions increase risk of idiopathic generalized epilepsy
Ingo Helbig;Heather C. Mefford;Andrew J. Sharp;Michel Guipponi.
Nature Genetics (2009)
Analysis of shared heritability in common disorders of the brain
Verneri Anttila;Verneri Anttila;Brendan Bulik-Sullivan;Brendan Bulik-Sullivan;Hilary K. Finucane;Raymond K. Walters;Raymond K. Walters.
Science (2018)
Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies
Carolien G F De Kovel;Holger Trucks;Ingo Helbig;Heather C. Mefford.
Brain (2010)
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
Timothy R.D.J. Radstake;Olga Y Gorlova;Blanca Rueda;Jose Ezequiel Martin.
Nature Genetics (2010)
Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect
Alienke J Monsuur;Paul I W de Bakker;Paul I W de Bakker;Behrooz Z Alizadeh;Alexandra Zhernakova.
Nature Genetics (2005)
KIR in Type 1 Diabetes: Disparate Distribution of Activating and Inhibitory Natural Killer Cell Receptors in Patients Versus HLA-Matched Control Subjects
Arno R. van der Slik;Bobby P.C. Koeleman;Willem Verduijn;G. Jan Bruining.
Diabetes (2003)
Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia
T G W Letteboer;J J Mager;R J Snijder;B P C Koeleman.
Journal of Medical Genetics (2005)
Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases.
Alexandra Zhernakova;Behrooz Z. Alizadeh;Behrooz Z. Alizadeh;Marianna Bevova;Miek A. van Leeuwen.
American Journal of Human Genetics (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Children's Hospital of Philadelphia
Utrecht University
University of Southern Denmark
University of Antwerp
University of Genoa
University Medical Center Groningen
University of Genoa
Leiden University Medical Center
University of Tübingen
University of Helsinki
IBM (United States)
Texas Instruments (United States)
University of Girona
University of Tokyo
Hiroshima University
University of Würzburg
University of Manchester
National Autonomous University of Mexico
Instituto de Medicina Tropical Alexander von Humboldt
Yokohama City University
Universidade de São Paulo
Montreal Neurological Institute and Hospital
University of Colorado Boulder
University of Missouri
Stanford University
University of Michigan–Ann Arbor